Serum Iron and Free Hemoglobin Concentrations in Patients with                              Acute Ischemia Stroke by Ghadiani, Faezeh - et al.
 















1Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, Iran. 
2Cellular and Molecular Biology Research Center (CMBRC),Health Research Institute,  Babol University of Medical Sciences, 
Babol, Iran. 
3Department of Neurology, Ayatollah Rouhhani Hospital, Babol University of Medical Sciences, Babol, Iran. 
 




     A number of evidences suggest that during ischemic stroke, serum iron and hemoglobin (Hb) levels are 
changed. Yet, there are few reports in the literature related to this issue and resolution of this mechanism 
requires further experiments. The aim of the present study was to investigate the potential role of serum iron 
and hemoglobin levels as a  biomarker in diagnosis of acute ischemic stroke.  The sample size was  60 
ischemic  stroke patients who were admitted to the Rouhhani hospital in Babol, with 60 healthy volunteers 
selected as control group. Clinical evaluation consisted of complete medical history and physical 
examination and neuro-imaging's  studies. Sampling strategy was  based on clinical characteristics, including 
age, gender, and history of diseases. Laboratory measurements were performed in the department of clinical 
biochemistry. Serum iron and plasma hemoglobin levels were measured by standard kit of iron and 
hemoglobin ELISA Kit, as of the manufactures' manual. Data were analyzed through statistical software 
SPSS version 22. The mean level of serum iron and hemoglobin in patients with acute ischemic stroke were 
higher than those in control group (P<0.05). However, there was no relation between these biomarkers and 
age and gender of subjects (P>0.05). Our results reinforce the possibility of serum iron and hemoglobin as 
biomarker in diagnosis of ischemic stroke patients.  
 
Keywords: Acute ischemic stroke; iron; hemoglobin 
 
INTRODUCTION 
     It has been previously reported that stroke is a 
serious neurological disease as the main leading 
cause of death and disability throughout the 
world. Recent evidence suggests that 
pathophysiology of stroke is highly complex and 
involves inflammatory pathways, oxidative 
damages, ionic imbalance and apoptosis. Many 
studies shows that brain damage is related to 
acidosis and that enhanced acidosis is detrimental 
because it accelerates delocalization of protein-
bound iron[1].Much evidence has been 
accumulated in recent years, indicating that it can 
be as an important element for the development of 
the nervous system. Preliminary studies revealed 
that alteplase has been used widely throughout the 
world for the treatment of acute ischemic stroke 
[2] There are some reports in the literature 
showing that disruption of iron homeostasis after 
ischemic stroke causes neuronal damage [3] It is 
well recognized that hemoglobin contributes to 
the pro-inflammatory nature of HDL in 
atherosclerosis [4] It is widely known that 
intravascular hemolysis releases large amounts of 
free hemoglobin.  There are some reports in the 
literature showing that serum-free hemoglobin 
concentrations in healthy individuals are related 
to haptoglobin type. It is well known that 
hemoglobinemia should be considered as a novel 
mechanism of human disease. There has been an 
increasing amount of reports on the fact that 
oxidative metabolism during ischemic stroke 
together with high iron content in the brain 
synergies to increase the oxidative damage. There 
is evidence that serum free hemoglobin is 
 




associated with stroke [5-8] It has been well 
established that the increase of serum hemoglobin 
in ischemic stroke leads to inflammation and 
coagulation. Previous work has shown that 
hemoglobinemia should be considered as a novel 
mechanism of disease and the serum ferritin level 
may reflect the iron storage of the body [7,9]. 
However, with the exception of a few 
publications, little information is available on the 
role of serum iron and hemoglobin in acute 
ischemic stroke; further work seems essential to 
explain the action. The aim of the present study 
was to investigate the potential role of serum iron 
and hemoglobin as biomarkers in diagnosis of 
acute ischemic stroke. 
 
MATERIALS AND METHODS  
Subjects 
     The present study is performed through case-
control, using sampling strategy and sampling 
frame. This study was conducted according to the 
guidelines of the declaration of Helsinki , and all 
procedures involving human patients were 
approved by our university ethics committee (4-
57-2013.5.7). The study protocol was reviewed 
and approved by the ethical committee of Babol 
University of Medical Sciences. Written informed 
consent was obtained from all patients after a full 
explanation of the purpose and nature of all 
procedures was provided. After all participants 
had signed the informed consent, serum iron and 
hemoglobin level were measured. Ischemic stroke 
was defined by focal neurological signs in a 
vascular territory of brain [4].  In this study, 
[n=60, 4 subjects were excluded], 56 (21 men and 
35 women) acute ischemic stroke patients with 
mean age of 64 years old were admitted in 
emergency department of Babol Rouhhani 
Hospital. Acute ischemic stroke was diagnosed by 
a specialist, based on the clinical variables such as 
patient's history, physical examination and neuro-
imaging studies. For the correct standard group, 
[n=60, 6 subjects were excluded], 54 (20 men and 
34 women) persons were selected as a control 
group with mean age of 62 years old.  The 
inclusion criteria was defined as acute ischemic 
stroke which should not last more than 24 hours 
after the onset of symptoms. Exclusion Criteria 
included: hemolysis sample for measuring iron 
and hemoglobin. a previous diagnosis of  kidney, 
Liver, and  heart disease. Moreover, subjects with 
blood and digestive diseases were excluded. 
Clinical characteristics, including age, gender, 
and history of diseases were obtained from their 
records. Whether patients smoke and duration of 
smoking was also asked and recorded from their 
relatives. According to inclusion and exclusion 
criteria in group 1, 56 acute ischemic stroke 
patients and in group 2, 54 healthy subjects were 
included and 10 subjects were excluded.  Written 
consent was received from all patients. Blood 
samples (3 ml) were taken from these patients; 
serum was then separated and kept at -80 ° C, in 
the department of bbiochemistry.  
Measurements 
     Iron level was determined by the using 
standard kit at 600 nm , according to the 
manufacturers instruction (Bioassay Technology 
Laboratory Company). Quantification of plasma 
hemoglobin levels in all samples were performed 
through using human hemoglobin ELISA kit at 
450 nm (Bioassay Technology Laboratory 
Company). 
Statistical analysis 
     Descriptive statistics and analysis were 
performed in SPSS 20.0 for Windows. All values 
are expressed as mean ± standard error. 
Probability values P< 0.05 were considered as 
statistically significant. Correlation values were 
evaluated by Spearman's correlation test. 
independence sample t-test was also used.  
 
RESULTS 
     In this study, 56 patients and 54 persons as 
control group were examined. The two groups 
were matched for the demographical variables 
like  sex , education and age. Variables have 
normal distribution and we used parametric 
method for analysis. The serum iron level for 
patients and control group is shown in figure 
There is significant increase in iron level of 
patients' group in comparison with control group 
(p=0.009). Age and sex did not show any 
significant correlation with iron (for age  rs=0.05, 
P=0.58), (for gender  rs=0.117, P=0.203). No 
significant correlation was found between 
hemoglobin and iron level (rs=0.021, P=0.818).  
 





























Figure 1. Mean serum iron concentration in patient and control groups. 
 
The mean plasma hemoglobin level for patients 
and control group are shown in figure. There is 
significant increase in hemoglobin level of 
patients' group compared to control group 
(P=0.022). Age and sex did not show any 
significant correlation with hemoglobin (for age 
rs=-0.07, P=0.448), (for gender rs=0.059, 
P=0.52). No significant correlation was found 

























   Figure 2. Mean plasma Hb concentration in patients and control group 
 




To determine the ability of each indicator to 
differentiate between healthy subjects and 
patients,  AUC in serum case for iron and 
hemoglobin were reported (figure 3and table 1).  
 


















Figure 3. Markers ROC in serum case in comparison with 
 serum control 
 
DISCUSSION
     Results of this study demonstrated that serum 
iron levels were increased in ischemic stroke 
patients compared to the control group. Our 
results were in agreement with what other 
researchers reported previously [10]. Likewise, 
findings of this study demonstrated that plasma 
hemoglobin levels were increased compared with 
the control group. Elevated plasma Hb level 
might be due to severity of desecration of RBCs, 
decreased intravascular Hb-scavenger level and 
organ dysfunction in stroke patients.  The action 
mechanism remains unclear and further studies 
are needed to clarify this mechanism. Further 
basic and clinical experimental investigations 
seem essential to explore the role of Hb in stroke 
patients. Our study on stroke is in progress to 
elucidate its mode of action. In terms of future 
applications, we will examine this problem in 
more details as we go forward. Our results are in 
perfect harmony with those reported previously 
[11] These results strongly suggest that our 
findings  
could provide new possibility of serum iron and 
plasma hemoglobin as biomarker in diagnosis of 
ischemic stroke patients. The strong point of 
present study is the introduction of the possibility 
of serum iron and hemoglobin levels as biomarker 
in early diagnosis of ischemic stroke patients. On 
the other hand, decreased iron and hemoglobin 
level cause decrease in oxygen content of blood 
and oxygen to the brain and ultimately causing 
damage to the brain cells [12]. Because of the 
influence of iron stores, contamination and 
hemolysis, ferritin measurement is more 
appropriate than serum iron in brain injury [13]. 
The previous results from our laboratory 
confirmed the possibility of serum iron and 
hemoglobin levels as the potential biomarkers in 
diagnosis of acute ischemic stroke. Yet, beside all 
these positive results and suggestions, many more 
experiments are needed to address this issue. To 
that end, deeper investigations are being carried 
out in our laboratory . 
 
CONCLUSION  
     What makes this study creative is introducing 
the possibility of serum iron and hemoglobin as 
biomarker in early diagnosis of ischemic stroke 
patients. Serum iron and hemoglobin levels can 
































































promising that serum iron and hemoglobin will 
play an important diagnostic role in ischemic 
stroke disease. 
Limiting the findings 
     We couldn’t discuss on why we did not see 
any relationship between demographical variable 
like sex and age with serum iron and hemoglobin 
level changes.  
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